Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and rare diseases; digital health solutions; and health data services. It serves patients, healthcare providers, biopharma companies, and other partners. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was incorporated in 2010 and is headquartered in San Francisco, California.
Invitae was founded in 2012 by Sean George and Randy Scott and is based in San Francisco, California. In its first years, Invitae focused on building its technology infrastructure and expanding its clinical laboratory. 2012 also saw the launch of Invitae's hereditary cancer testing service.
At Invitae, we strive to make genetics accessible to everyone by providing comprehensive, affordable and accessible genetic testing and information services.
Invitae believes that the power of genetics can lead to the prevention, diagnosis and treatment of the world’s most devastating diseases.
Dr. Robert L. Nussbaum M.D. (Chief Medical Officer)
Ms. Shelly D. Guyer (Chief Sustainability Officer)
Mr. Robert F. Werner (Chief Accounting Officer & Principal Accounting Officer)
Ms. Hoki Luk (Head of Investor Relations and Capital Markets)
Mr. Lee Bendekgey J.D. (Chief Policy Officer)
Glenn Medalle (Head of Talent)
Ms. Desarie French (Chief Talent Officer)
Recognition and Awards
Invitae has been honored with numerous awards for its innovation and revolutionary approach to transforming healthcare with genetics.